Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment

Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment

We described the case of a patient affected by activated PI3K-kinase delta syndrome (APDS) and a long-lasting and pauci-symptomatic SARS-CoV-2 infection, treated with multiple therapeutic agents including remdesivir and SARS-CoV-2-neutralizing monoclonal antibodies. We detected the clearance of the...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид: Beatrice Rivalta, Donato Amodio, Carmela Giancotta, Veronica Santilli, Lucia Pacillo, Paola Zangari, Nicola Cotugno, Emma Concetta Manno, Andrea Finocchi, Stefania Bernardi, Luna Colagrossi, Leonarda Gentile, Cristina Russo, Carlo Federico Perno, Paolo Rossi, Caterina Cancrini, Paolo Palma
Формат: Өгүүллэг
Хэл сонгох:English
Хэвлэсэн: Frontiers Media S.A. 2022-06-01
Цуврал:Frontiers in Immunology
Нөхцлүүд:
SARS-CoV-2
COVID19
IEI
activated PI3K delta syndrome (APDS)
monoclonal antibody
remdesivir
Онлайн хандалт:https://www.frontiersin.org/articles/10.3389/fimmu.2022.891274/full

Интернэт

https://www.frontiersin.org/articles/10.3389/fimmu.2022.891274/full

Ижил төстэй зүйлс